| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/03/2002 | CN1343120A Essential fatty acids in prevention of cardiovascular events |
| 04/03/2002 | CN1343119A Medicinal compositions retarded in discoloration of phenolic hydroxyl compounds |
| 04/03/2002 | CN1343118A Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 04/03/2002 | CN1343117A Method for improving stability of stored and/or used light-sensitive therapeutic systems or components thereof |
| 04/03/2002 | CN1343116A Metered dose inhalers with isobutane as propellant |
| 04/03/2002 | CN1343115A Skin sanitizing compositions |
| 04/03/2002 | CN1343100A Food complement and cosmetic treatment based on grape extract rich in polyphenols |
| 04/03/2002 | CN1342656A Cyclobornane triterpenoid saponin compound and its application in immunosuppresion and treating tumor |
| 04/03/2002 | CN1342654A C21 steriod glycoside extracted from white fleece flower root with antineoplastic function |
| 04/03/2002 | CN1342653A 1,6-fructostrontium biphosphate compounds and their preparing process and medical application |
| 04/03/2002 | CN1342651A Ganciclovir sodium hydrate and its preparing process and application |
| 04/03/2002 | CN1342491A Medicine 'Suyusan' for treating intractable ulcer |
| 04/03/2002 | CN1342490A Process for preparing staltic-antagic medicine to treat trauma |
| 04/03/2002 | CN1342484A Pile ointment |
| 04/03/2002 | CN1342458A Application of leflunomide in preparing medicines to treat lupoid nephritis and nephrotic syndrome |
| 04/03/2002 | CN1342457A Method for preventing vomit and sexual disorder using tetrahydrobenzo [cd] indole-6-formylamine compound |
| 04/03/2002 | CN1342456A Process for preparing medicine to prevent and cure diabetes, hyperlipomia and obesity |
| 04/03/2002 | CN1342455A Liniment for preventing pig bite |
| 04/03/2002 | CN1082050C Azole cojpounds endowed with antimycotic activity for human and veterinary use |
| 04/03/2002 | CN1081951C Use of ion exchange resins loader with quioolonecarboxylic acid derivatives |
| 04/03/2002 | CN1081928C Preparation of medicine for curing burns and scalds |
| 04/03/2002 | CN1081925C Oil ointment of chirita longangensis for treating hurns and its preparation method |
| 04/03/2002 | CN1081924C Pharmaceutical composition comprising plant worms and muirapuama |
| 04/03/2002 | CN1081923C Chitosan and use of polysaccharide fixed on it in producing hard tissue irritant |
| 04/03/2002 | CN1081922C Medicinal composition containing ginsenoside Re preparation, preparation method and usage thereof |
| 04/03/2002 | CN1081921C Molten granulated sucralfate preparation and process for producing same |
| 04/03/2002 | CN1081920C Herba pteridis semipinnatae extract and its medicinal composite |
| 04/03/2002 | CN1081919C Preparation for skin and mucous membrane |
| 04/03/2002 | CN1081918C Use of Selegilin in the treatment of epilectic conditions |
| 04/03/2002 | CN1081917C Medicine composition for deep tumor by local treatment, and using same in pharmaceutic |
| 04/02/2002 | USRE37623 Enzyme inhibitors, their synthesis, and methods for use |
| 04/02/2002 | US6365787 Compounds for the suppression of HIV TAT transactivation |
| 04/02/2002 | US6365775 Biphenyl compounds and their use as oestrogenic agents |
| 04/02/2002 | US6365768 Interleukin-1 and tumor necrosis factors-α modulators, syntheses of said modulators and methods of using modulators |
| 04/02/2002 | US6365759 Intermediate compounds for preparing macrocylcic analogs |
| 04/02/2002 | US6365751 Antibiotic oxazolidinone derivatives |
| 04/02/2002 | US6365749 Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 04/02/2002 | US6365747 Method for the preparation of citalopram |
| 04/02/2002 | US6365736 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 04/02/2002 | US6365715 Human cardiac/brain tolloid-like protein |
| 04/02/2002 | US6365712 Isolated soluble cd antigen; diagnosis and treatment of related disorders |
| 04/02/2002 | US6365664 Gels formed by the interaction of poly(aldehyde) with various substances |
| 04/02/2002 | US6365635 Topical applying; stability |
| 04/02/2002 | US6365634 Cumylphenol; nonsteroidal antiinflammatory agent; from peat bog |
| 04/02/2002 | US6365633 Method of treating eating disorders |
| 04/02/2002 | US6365632 N,n-dimethyl-1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutylami ne |
| 04/02/2002 | US6365631 Method of treating sleep apnoea |
| 04/02/2002 | US6365630 Compositions and methods for inhibiting photoaging of skin |
| 04/02/2002 | US6365628 Fatty analogues for the treatment of diabetes |
| 04/02/2002 | US6365627 Method for treating a patient with neoplasia by treatment with a paclitaxel derivative |
| 04/02/2002 | US6365626 Leflunomide metabolite analogs for treating improper platelet aggregation; leukemia; lymphomas |
| 04/02/2002 | US6365625 Narrow or mono-dispersed naphthalenesulfonic acid formaldehyde condensation polymers of a molecular weight minimizing anticoagulation; antigens |
| 04/02/2002 | US6365624 Method and composition for delivering zinc to the nasal membrane |
| 04/02/2002 | US6365623 Treatment of acne using lipoic acid |
| 04/02/2002 | US6365622 Antioxidant composition comprising acetyl L-carnitine and α-lipoic acid |
| 04/02/2002 | US6365621 Remedies or preventives for intractable epilepsy |
| 04/02/2002 | US6365619 Cyclic oligopeptide vcam-1 inhibitor; (s)-.beta.-(3-methoxypropyl) ((4-((2-methylphenylaminocarbonylamino)-phenyl) acetyl)amino)acetyl-amino-3,4-dimethoxy-benzenepropanoic acid |
| 04/02/2002 | US6365618 Counteracts effects of antipsychotics or antiemetics which block dopamine receptors |
| 04/02/2002 | US6365616 Transplant rejection |
| 04/02/2002 | US6365612 Benzosultam oxazolidinone antibacterial agents |
| 04/02/2002 | US6365611 Pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same |
| 04/02/2002 | US6365610 1,4-epoxy-2,3-benzodioxepins or 1,4-epoxy-3,2-benzoxazepines |
| 04/02/2002 | US6365609 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 04/02/2002 | US6365607 Thiazolidinedione and oxazolidinedione compounds for treatment of diabetic anemia, edema, and anorexia |
| 04/02/2002 | US6365605 Substituted hydrochromenopyrroles |
| 04/02/2002 | US6365604 For therapy of psychotic disorders |
| 04/02/2002 | US6365603 Aromatic compounds and pharmaceutical compositions containing them |
| 04/02/2002 | US6365602 For therapy of depression, anxiety, asthma, pain, inflammation, urinary incontinence and other disease conditions |
| 04/02/2002 | US6365600 For therapy of condition associated with smooth muscle cell proliferation in a warm-blooded animal which comprises administering imidazol-5-yl-methyl-2-quinolinone derivatives |
| 04/02/2002 | US6365599 For therapy of benign prostatic hyperplasia |
| 04/02/2002 | US6365598 Pyrroloquinolines for treatment of obesity |
| 04/02/2002 | US6365596 Stability, shelf-life |
| 04/02/2002 | US6365594 As opioid agonists and antagonists and are useful as i.a. analgesics |
| 04/02/2002 | US6365593 Methylxanthines in the diagnosis and treatment of autistic disorder |
| 04/02/2002 | US6365590 Compounds, compositions and methods for treating erectile dysfunction |
| 04/02/2002 | US6365588 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 04/02/2002 | US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/02/2002 | US6365583 Methods to enhance white blood cell count |
| 04/02/2002 | US6365582 S-substitute 11β-benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds |
| 04/02/2002 | US6365581 Administering to surfaces of airway passages or lungs aerosolized particles of mometasone furoate effective for treating corticosteroid-responsive disease of lower airway passages or lungs, resulting in negligible systemic effects |
| 04/02/2002 | US6365579 Nitrate esters and their use for neurological conditions |
| 04/02/2002 | US6365578 Drug cominbations containing AZT |
| 04/02/2002 | US6365577 Administering to the subject, in a suitable pharmaceutical carrier, a pharmaceutically effective amount of an antisense agent which is morpholino oligonucleotide for inhibiting expression of p53 |
| 04/02/2002 | US6365575 Gene delivery and expression in areas inaccessible to direct protein delivery |
| 04/02/2002 | US6365574 Gradual crystallization of azithromycin from ethanol by the addition of a minimal amount of water; hydrophobic |
| 04/02/2002 | US6365571 FGF inhibitor, angiogenesis inhibitor and antitumor agent containing complestatin or its derivative as effective ingredient |
| 04/02/2002 | US6365414 Vitro system for determining formation of Aβ amyloid |
| 04/02/2002 | US6365402 Growth differentiation factor-9 |
| 04/02/2002 | US6365393 Recombinant virus with an insertion in the hind iii fragment i region; immunomodulators |
| 04/02/2002 | US6365389 Human protein kinase H2LAU20 |
| 04/02/2002 | US6365370 Dna which codes for 5-hydroxytryptamine 3-c protein of defined amino acid sequence; antiinflammatory agents; treatment of huntington's disease, alzheimer's disease and others |
| 04/02/2002 | US6365364 Contacting plasminogen with kringle-4 protease to produce fragments of 50-70 kilodaltons, contacting fragments with elastase or plasmin to cleave ones containing first 50-80 amino acids of plasminogen, then isolating inhibitors |
| 04/02/2002 | US6365359 Identifying prp pharmacore by determining functional residues of protein involved in complex interactions, developing three dimensional structures, comparing them with other compounds and identifying compounds consistent with binding to protein |
| 04/02/2002 | US6365351 Non-invasive method for detecting target RNA |
| 04/02/2002 | US6365345 Antisense nucleic acids for the prevention and treatment of disorders in which expression of c-erbB plays a role |
| 04/02/2002 | US6365343 Treating rhinovirus infection by using insufflate for nasal administration composed of soluble interacellular adhesion molecule, type i; a bulking agent; and carboxymethyl cellulose, sodium salt |
| 04/02/2002 | US6365218 Xanthan gum hydrocolloid |
| 04/02/2002 | US6365200 Topical skin sensitizer comprising water soluble gel vehicle and active ingredients consisting of benzalkonium chloride, vitamin e, and aloe; aphrodisiac |
| 04/02/2002 | US6365197 Antibacterial composition comprising Oenostacin from Oenothera biennis |
| 04/02/2002 | US6365192 Bioactivating substance |